XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
REVENUE (Tables)
9 Months Ended
Jul. 31, 2022
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The following table presents the company’s total revenue and segment revenue disaggregated by geographical region:
Three Months Ended July 31,
20222021
Life Sciences and Applied MarketsAgilent CrossLab
Diagnostics and Genomics
TotalLife Sciences and Applied MarketsAgilent CrossLab
Diagnostics and Genomics
Total
(in millions)
Revenue by Region
Americas$336 $147 $188 $671 $289 $130 $187 $606 
Europe210 94 103 407 218 94 111 423 
Asia Pacific473 118 49 640 390 119 48 557 
Total$1,019 $359 $340 $1,718 $897 $343 $346 $1,586 
Nine Months Ended July 31,
20222021
Life Sciences and Applied MarketsAgilent CrossLab
Diagnostics and Genomics
TotalLife Sciences and Applied MarketsAgilent CrossLab
Diagnostics and Genomics
Total
(in millions)
Revenue by Region
Americas$974 $416 $577 $1,967 $864 $376 $502 $1,742 
Europe678 289 314 1,281 677 281 317 1,275 
Asia Pacific1,239 366 146 1,751 1,160 346 136 1,642 
Total$2,891 $1,071 $1,037 $4,999 $2,701 $1,003 $955 $4,659 
The following table presents the company’s total revenue disaggregated by end markets and by revenue type:
Three Months EndedNine Months Ended
July 31,July 31,
2022202120222021
(in millions)
Revenue by End Markets
Pharmaceutical and Biopharmaceutical$643 $576 $1,834 $1,628 
Chemical and Energy389 334 1,097 976 
Diagnostics and Clinical234 242 718 691 
Food151 143 446 449 
Academia and Government139 138 426 423 
Environmental and Forensics162 153 478 492 
Total$1,718 $1,586 $4,999 $4,659 
Revenue by Type
Instrumentation$737 $640 $2,074 $1,953 
Non-instrumentation and other981 946 2,925 2,706 
Total$1,718 $1,586 $4,999 $4,659 
Contract Liabilities and Changes in Balances
The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the nine months ended July 31, 2022:
Contract
Liabilities
(in millions)
Ending balance as of October 31, 2021$519 
Net revenue deferred in the period391 
Revenue recognized that was included in the contract liability balance at the beginning of the period(336)
Change in deferrals from customer cash advances, net of revenue recognized39 
Currency translation and other adjustments(25)
Ending balance as of July 31, 2022$588